1. Home
  2. NODK vs OBIO Comparison

NODK vs OBIO Comparison

Compare NODK & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NODK

NI Holdings Inc.

HOLD

Current Price

$14.88

Market Cap

302.0M

Sector

Finance

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$6.10

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NODK
OBIO
Founded
1946
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
302.0M
253.9M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
NODK
OBIO
Price
$14.88
$6.10
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $14.25
AVG Volume (30 Days)
29.1K
★ 303.9K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.13
EPS
★ 0.61
N/A
Revenue
★ $285,050,000.00
$33,482,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.43
P/E Ratio
$24.52
★ N/A
Revenue Growth
N/A
★ 1169.22
52 Week Low
$12.37
$2.50
52 Week High
$16.70
$6.48

Technical Indicators

Market Signals
Indicator
NODK
OBIO
Relative Strength Index (RSI) 45.48 57.56
Support Level $13.00 $5.71
Resistance Level $16.44 $6.48
Average True Range (ATR) 0.50 0.36
MACD -0.01 -0.05
Stochastic Oscillator 32.55 23.12

Price Performance

Historical Comparison
NODK
OBIO

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. Through its subsidiaries, the company operates in the insurance industry, offering homeowners and farmowners insurance policies, crop insurance policies, home insurance policies, etc. These insurance products are distributed through a network of exclusive and independent agents across the United States. The group's reportable segments are: Private Passenger Auto, Non-Standard Auto, Home and Farm, Crop, and All Other (which mainly consists of commercial, assumed reinsurance, and its excess liability business). Maximum revenue is generated from the Home and Farm segment.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: